Pune, Maharashtra -- (SBWIRE) -- 10/11/2022 -- The artificial fertilization procedure known as in vitro fertilization (IVF) takes place outside of the female body. The women's eggs are surgically extracted and fertilized in a lab by a sperm. Women who are having trouble becoming pregnant frequently use in vitro fertilization. In the clinical field, IVF techniques have become the preferred option for reproductive treatments. IVF is one of the often utilized procedures for helping infertile couples, single mothers, and members of the LGBT community have children.
According to the latest market research report published by the SNS Insider, the in-vitro fertilization (IVF) services market is anticipated to cross hit USD 1163 million by 2028, with a CAGR of 8.9% during the forecast period of 2022–2028.

Book Your Free Sample Report @ https://www.snsinsider.com/sample-request/1053?utm_source=KailasRW

Drivers, Restraints, Opportunities, and Challenges
Pre-implantation genetic diagnosis (PGD) and three-parent IVF procedures are two examples of recent technology developments that are expected to significantly boost the market in-vitro fertilization (IVF) services market. Reduced rates of conception, postponed pregnancies, shifting lifestyle conditions, and reproductive diseases are the main drivers of market expansion. Future endeavors to commercialize affordable therapies and the emergence of medical tourism, particularly in underdeveloped countries, may present attractive growth prospects for IVF service providers. Additionally, the expanding clinical research activities for the creation of cutting-edge IVF technologies would offer a foundation for the expansion of the IVF market globally.
On the other side, obstacles including ethical issues with IVF in specific nations, high IVF process costs, and low awareness, particularly in underdeveloped economies like Nigeria, are likely to stifle market expansion.

Impact of the COVID-19 Pandemic
The impact of the COVID-19 pandemic on the in-vitro fertilization (IVF) services market is anticipated to be considerable owing to the fact that most nations have implemented their own tactics to stop and stop the transmission of the coronavirus. The healthcare guidelines also included delaying the start of new therapies and taking the cryopreservation of gametes into consideration in cases of urgent fertility preservation. The COVID-19 pandemic is therefore anticipated to have a substantial effect on the development of the market.

Market Segmentation
By End-User
1.Fertility Clinics
2.Hospitals
3.Surgical centers
4.Clinical research institute
5.Cryobanks

By Cycle Type
1.Fresh IVF Cycles (Non-Donor)
2.Thawed IVF Cycles (Non-Donor)
3.Donor Egg IVF Cycle
4.Frozen Non-donor IVF Cycles
5.Frozen Donor IVF Cycles

By Product
1.Equipment
a.Sperm Analyzer Syate
b.Imaging System
c.Ovum Aspiration Pumps
d.Incubators
e.Micromanipulator Systems
f.Laser system
g.Gas Analyzer
h.Sperm Separation Devices
i.IVF Cabinets
j.Cryosystems
k.Witness Systems
l.Anti-Vibration Tables
m.Other Equipments
2.Reagents & Media
a.Cryopreservation Media
b.Sperm Processing Media
c.Ovum Processing Media
d.Embryo Culture Media
e.Accessories

By Type
1.Conventional IVF
2.IVF with ICSI
3.IVF with Donar Eggs
4.Others

The segment for sperm separation devices is predicted to have the biggest market share throughout the projection period. Sperm separation methods are employed in the majority of assisted reproductive technologies (ARTs), including in vitro fertilization (IVF) and artificial insemination. Because they offer pure samples that can be used in subsequent operations, these systems are essential for ARTs.
The fertility clinics sector dominated the IVF market in terms of end-use, accounted for the biggest revenue share, and is anticipated to see the quickest CAGR over the course of the forecast period. The demand for ART treatments is increasing, which has led to a significant rise in the number of fertility clinics and ART facilities.

Regional Analysis
North America now maintains a sizeable market share, and it is anticipated that it will continue to do so during the projection period. Due to the increased prevalence of related disorders including polycystic ovary syndrome, the in vitro fertilization market in North America is anticipated to expand rapidly over the next years (PCOS). The in-vitro fertilization (IVF) services market in the region is anticipated to be driven by a consistent rise in the prevalence of infertility in both sexes. The market for in vitro fertilization (IVF) services is dominated by Asia Pacific. The significant growth of the clinical travel industry, increased awareness of the accessibility of in vitro preparation techniques, decreased IVF treatment methods, rising use of medical services, and evolving acceptance of conceptual innovation all contributed to conceptual innovation in the major nations.

Competitive Landscape Outlook
Some of the prominent companies present in the in-vitro fertilization (IVF) services market include Esco Micro Pte. Ltd., Hamilton Thorne Ltd., Cooper Companies Inc., IVFtech ApS, and ZEISS Group, Thermo Fisher Scientific, Inc., Kitazato Corporation, Cook Group, and The Baker Company Inc.

Buy This Exclusive Report @ https://www.snsinsider.com/checkout/1053?utm_source=KailasRW

Table Of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges

4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact Of Ukraine Ware

5. Value Chain Analysis

6. Porter's 5 Forces Model

7.  PEST Analysis

8. In Vitro Fertilization (IVF) Service Market Segmentation, By Cycle Type
8.1 Fresh IVF Cycles (Non-Donor)
8.2 Thawed IVF Cycles (Non-Donor)
8.3 Donor Egg IVF Cycle

9. In Vitro Fertilization (IVF) Service Market Segmentation, By Product
9.1 Equipment
9.1.1 Sperm Analyzer Syate
9.1.2 Imaging System
9.1.3 Ovum Aspiration Pumps
9.1.4 Incubators
9.1.5 Micromanipulator Systems
9.1.6 Laser System
9.1.7 Gas Analyzer
9.1.8 Sperm Separation Devices
9.1.10 IVF Cabinets
9.1.11Cryosystems
9.1.12 Witness Systems
9.1.13 Anti-Vibration Tables
9.1.14 Other Equipment's
9.2 Reagents & Media
9.2.1 Cryopreservation Media
9.2.2 Sperm Processing Media
9.2.3 Ovum Processing Media
9.2.4 Embryo Culture Media
9.3 Accessories

10. In Vitro Fertilization (IVF) Service Market Segmentation, By Type
10.1 Conventional IVF
10.2 IVF With ICSI
10.3 IVF With Donar Eggs
10.4 Others

11. In Vitro Fertilization (IVF) Service Market Segmentation, By End User
11.1 Fertility Clinics
11.2 Hospitals
11.3 Surgical Centers
11.4 Clinical Research Institute
11.5 Cryobanks
 
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 USA
12.2.2 Canada
12.2.3 Mexico
12.3     Europe
12.3.1 Germany
12.3.2 UK
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 The Netherlands
12.3.7 Rest Of Europe
12.4     Asia-Pacific
12.4.1 Japan
12.4.2 South Korea
12.4.3 China
12.4.4 India
12.4.5 Australia
12.4.6 Rest Of Asia-Pacific
12.5     The Middle East & Africa
12.5.1 Israel
12.5.2 UAE
12.5.3 South Africa
12.5.4 Rest
12.6     Latin America
12.6.1 Brazil
12.6.2 Argentina
12.6.3 Rest Of Latin America

13. Company Profiles
13.1 Cooper Companies Inc.
13.1.1 Financial
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS View
13.2 Cook Group (US)
13.3 Vitrolife
13.4 Thermo Fisher Scientific, Inc.
13.5 Esco Micro Pte. Ltd.
13.6 Genea Limited
13.7 IVFtech ApS
13.8 FUJIFILM Irvine Scientific
13.9 Kitazato Corporation
13.10 Corning Corporation

14. Competitive Landscape
14.1 Competitive Benchmark
14.2 Market Share Analysis
14.3 Recent Developments
 
15. Conclusion

Contact Us:
Akash Anand
Head of Business Development & Strategy
info@snsinsider.com
IND: +91-7798602273
US: +1-415-230-0044